These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6138775)

  • 21. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of oral dyskinesias in naive rats by D1 stimulation.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Life Sci; 1983 Dec; 33(25):2479-82. PubMed ID: 6227782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
    Schechter MD; Greer NL
    Life Sci; 1987 Jun; 40(25):2461-71. PubMed ID: 2953944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover].
    Bernasconi R; Steulet AF; Aryee D; Martin P; Leonhardt T; Bischoff S; Maitre L
    Encephale; 1989; 15(4):377-85. PubMed ID: 2572414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
    Morelli M; Fenu S; Cozzolino A; Di Chiara G
    Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Neuroreport; 1991 Aug; 2(8):451-4. PubMed ID: 1832988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY; Hata F; Ohashi T; Goldstein M
    J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine agonists used in the treatment of Parkinson's disease and their selectivity for the D1, D2, and D3 dopamine receptors in human striatum.
    De Keyser J; De Backer JP; Wilczak N; Herroelen L
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1147-54. PubMed ID: 8787038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats.
    Koshikawa N; Koshikawa F; Tomiyama K; Kikuchi de Beltrán K; Kamimura F; Kobayashi M
    Eur J Pharmacol; 1990 Jul; 182(2):375-80. PubMed ID: 1975784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation between D1- and D2-dopamine receptors in the nucleus accumbens.
    Szmigielski A; Zalewska-Kaszubska J
    Neuropharmacology; 1991 Mar; 30(3):259-66. PubMed ID: 1830133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.